Anti-thrombopoietin antibodies suppress megakaryocyte colony formation in vitro in patients with systemic lupus erythaematosus

Annals of the Rheumatic Diseases

Volumn 67, Issue 11, 2008, Pages 1643-1644

  Ziakas, P D ^a   Papadaki, H A ^b   Psyllaki, M ^b   Voulgarelis, Michael ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; THROMBOPOIETIN;

ANTIBODY DETECTION; CELL MATURATION; COLONY FORMATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LETTER; MEGAKARYOCYTE; MEGAKARYOPOIESIS; MONONUCLEAR CELL; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

AUTOANTIBODIES; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MEGAKARYOCYTES; THROMBOPOIETIN;

EID: 54349126471     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.087478     Document Type: Letter

References (11)

1. Ziakas PD, Routsias JG, Giannouli S, Tasidou A, Tzioufas AG, Voulgarelis M. Suspects in the tale of lupus-associated thrombocytopenia. Clin Exp Immunol 2006;145:71-80.
2. Fureder W, Firbas U, Nichol JL, Pistillo J, Winkler S, Hiesberger H, et al. Serum thrombopoietin levels and anti-thrombopoietin antibodies in systemic lupus erythematosus. Lupus 2002;11:221-6.
3. Chang M, Nakagawa PA, Williams SA, Schwartz MR, Imfeld KL, Buzby JS, et al. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro. Blood 2003;102:887-95.
4. Psyllaki M, Damianaki A, Gemetzi C, Pyrovolaki K, Eliopoulos GD, Papadaki HA. Impaired megakaryopoiesis in patients with chronic idiopathic neutropoenia is associated with increased transforming growth factor β1 production in the bone marrow. Br J Haematol 2006;134:624-31.
5. Cox CV, Killick SB, Patel S, Elebute MO, Marsh JC, Gordon-Smith EC, et al. In vitro proliferation and differentiation of megakaryocyte: progenitors in patients with aplastic anemia, paroxysmal nocturnal hemoglobinuria, and the myelodysplastic syndromes. Stem Cells 2000;18:428-34.
6. Voulgarelis M, Ziakas PD, Tzioufas AG. Current Concepts in SLE Thrombocytopenia: From pathophysiology to therapeutic interventions Curr Rheumatol Rev 2006;2:359-67.
7. Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood 1995;86:419-31.
8. Ryu KH, Chun S, Carbonierre S, Im SA, Kim HL, Shin MH, et al. Apoptosis and megakaryocyte differentiation during ex vivo expansion of human cord blood CD34+ cells using thrombopoietin. Br J Haematol 2001;113:470-8.
9. Voulgarelis M, Giannouli S, Tasidou A, Anagnostou D, Ziakas PD, Tzioufas AG. Bone marrow histological findings in systemic lupus erythematosus with hematologic abnormalities: a clinicopathological study. Am J Hematol 2006;81:590-7.
10. Papadaki HA, Boumpas DT, Gibson FM, Jayne DR, Axford JS, Gordon-Smith EC, et al. Increased apoptosis of bone marrow CD34(+) cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus. Br J Haematol 2001;115:167-74.
11. Papadaki HA. Autoreactive T-lymphocytes are implicated in the pathogenesis of bone marrow failure in patients with systemic lupus erythematosus. Leuk Lymphoma 2003;44:1301-715.